The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995, 333: 1581-1587.
Article
Google Scholar
Wardlaw JM, Warlow CP, Counsell C: Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet. 1997, 350: 607-614. 10.1016/S0140-6736(97)03022-5.
Article
CAS
PubMed
Google Scholar
Scherbakov N, von Haehling S, Anker SD, Dirnagl U, Doehner W: Stroke induced Sarcopenia: muscle wasting and disability after stroke. Int J Cardiol. 2013, 170: 89-94. 10.1016/j.ijcard.2013.10.031.
Article
PubMed
Google Scholar
Dirnagl U: Pathobiology of injury after stroke: the neurovascular unit and beyond. Ann N Y Acad Sci. 2012, 1268: 21-25. 10.1111/j.1749-6632.2012.06691.x.
Article
PubMed
Google Scholar
White TA, Lebrasseur NK: Myostatin and sarcopenia: opportunities and challenges - A mini-review. Gerontology. 2014, 60 (4): 289-93. 10.1159/000356740.
Article
CAS
PubMed
Google Scholar
Siriett V, Salerno MS, Berry C, Nicholas G, Bower R, Kambadur R, Sharma M: Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol Ther. 2007, 15: 1463-1470. 10.1038/sj.mt.6300182.
Article
CAS
PubMed
Google Scholar
Whittemore L-A, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A: Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun. 2003, 300: 965-971. 10.1016/S0006-291X(02)02953-4.
Article
CAS
PubMed
Google Scholar
Sakuma K, Yamaguchi A: Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr Aging Sci. 2010, 3: 90-101. 10.2174/1874609811003020090.
Article
CAS
PubMed
Google Scholar
Xu L, Zhao P, Mariano A, Han R: Targeted myostatin gene editing in multiple mammalian species directed by a single pair of TALE nucleases. Mol Ther Nucleic Acids. 2013, 2: e112-10.1038/mtna.2013.39.
Article
PubMed Central
PubMed
Google Scholar
S-y Y: Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 1988, 9: 267-293. 10.1210/edrv-9-2-267.
Article
Google Scholar
Xia Y, Schneyer AL: The biology of activin: recent advances in structure, regulation and function. J Endocrino. 2009, 202: 1-12. 10.1677/JOE-08-0549.
Article
CAS
Google Scholar
Boström PA, Fernández-Real JM: Metabolism: Irisin, the metabolic syndrome and follistatin in humans. Nat Rev Endocrino. 2014, 10: 11-12.
Article
Google Scholar
Rodino Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR: Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve. 2009, 39: 283-296. 10.1002/mus.21244.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hedger M, de Kretser D: The activins and their binding protein, follistatin—diagnostic and therapeutic targets in inflammatory disease and fibrosis. Cytokine Growth Factor Rev. 2013, 24: 285-295. 10.1016/j.cytogfr.2013.03.003.
Article
CAS
PubMed
Google Scholar
Cheng J-C, Chang H-M, Qiu X, Fang L, Leung PC: FOXL2-induced follistatin attenuates activin A-stimulated cell proliferation in human granulosa cell tumors. Biochem Biophys Res Commun. 2014, 44: 537-542.
Article
Google Scholar
Rajput SK, Lee K, Zhenhua G, Di L, Folger JK, Smith GW: Embryotropic actions of follistatin: paracrine and autocrine mediators of oocyte competence and embryo developmental progression. Reprod Fertil Dev. 2014, 26: 37-47. 10.1071/RD13282.
Article
CAS
Google Scholar
Li ZB, Kollias HD, Wagner KR: Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem. 2008, 283: 19371-19378. 10.1074/jbc.M802585200.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhu J, Li Y, Lu A, Gharaibeh B, Ma J, Kobayashi T, Quintero AJ, Huard J: Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol. 2011, 179: 915-930. 10.1016/j.ajpath.2011.04.008.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee S-J: Induction of cachexia in mice by systemically administered myostatin. Science. 2002, 296: 1486-1488. 10.1126/science.1069525.
Article
CAS
PubMed
Google Scholar
Rong J, Tilton R, Shen J, Ng K-M, Liu C, Tam PK-H, Lau AS-Y, Cheng Y-C: Genome-wide biological response fingerprinting (BioReF) of the Chinese botanical formulation ISF-1 enables the selection of multiple marker genes as a potential metric for quality control. J Ethnopharmacol. 2007, 113: 35-44. 10.1016/j.jep.2007.01.021.
Article
CAS
PubMed
Google Scholar
C-z H, Wu F, Shen J, Lu L, Fu DL, Liao WJ, Zheng GQ: Clinical efficacy and safety of Buyang Huanwu Decoction for acute ischemic stroke: a systematic review and meta-analysis of 19 randomized controlled trials. Evid Based Complement Alternat Med. 2012, 2012: 630124-
Google Scholar
Qi H, Siu SO, Chen Y, Han Y, Chu IK, Tong Y, Lau AS, Rong J: Senkyunolides reduce hydrogen peroxide-induced oxidative damage in human liver HepG2 cells via induction of heme oxygenase-1. Chem Biol Interact. 2010, 183: 380-389. 10.1016/j.cbi.2009.11.029.
Article
CAS
PubMed
Google Scholar
Wei L, Liu J, Le XC, Han Y, Tong Y, Lau AS, Rong J: Pharmacological induction of leukotriene B4-12-hydroxydehydrogenase suppresses the oncogenic transformation of human hepatoma HepG2 cells. Int J Oncol. 2011, 39: 735-
CAS
PubMed
Google Scholar
Yang CBPW, Zhao J, Cheng YY, Zheng XH, Rong JH: Bornyl caffeate induces apoptosis in human breast cancer MCF-7 cells via the ROS- and JNK-mediated pathways. Acta Pharmacol Sin. 2014, 35: 113-123. 10.1038/aps.2013.162.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yan J, Tong S, Li J, Lou J: Preparative isolation and purification of amygdalin from prunus armeniaca L. with high recovery by high‒speed countercurrent chromatography. J Liq Chromatogr Relat Technol. 2006, 29 (9): 1271-1279. 10.1080/10826070600598985.
Article
CAS
Google Scholar
Fukuda T, Ito H, Mukainaka T, Tokuda H, Nishino H, Yoshida T: Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biol Pharm Bull. 2003, 26 (2): 271-273. 10.1248/bpb.26.271.
Article
CAS
PubMed
Google Scholar
Kim GJ, Choi HG, Kim JH, Kim SH, Kim JA, Lee SH: Anti-allergic inflammatory effects of cyanogenic and phenolic glycosides from the seed of Prunus persica. Nat Prod Commun. 2013, 8 (12): 1739-1740.
CAS
PubMed
Google Scholar
Koo JY, Hwang EY, Cho S, Lee JH, Lee YM, Hong SP: Quantitative determination of amygdalin epimers from armeniacae semen by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2005, 814 (1): 69-73. 10.1016/j.jchromb.2004.10.019.
Article
CAS
PubMed
Google Scholar
Yu L, Ye H, Zheng L, Chen L, Chu K, Liu X, Xu X, Chen G: Determination of the epimerization rate constant of amygdalin by microemulsion electrokinetic chromatography. Electrophoresis. 2011, 32 (2): 218-222. 10.1002/elps.201000287. 38
Article
CAS
PubMed
Google Scholar
Kosuge T, Ishida H, Ishii M: Studies on active substances in the herbs used for oketsu (" stagnant blood") in Chinese medicine. II. On the anticoagulative principle in persicae semen. Chem Pharm Bull (Tokyo). 1985, 33: 1496-1498. 10.1248/cpb.33.1496.
Article
CAS
Google Scholar
Tanaka R, Nitta A, Nagatsu A: Application of a quantitative 1H-NMR method for the determination of amygdalin in Persicae semen, Armeniacae semen, and Mume fructus. J Nat Med. 2014, 68: 225-230. 10.1007/s11418-013-0783-y.
Article
CAS
PubMed
Google Scholar
Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore L-A, Ahima RS, Khurana TS: Functional improvement of dystrophic muscle by myostatin blockade. Nature. 2002, 420: 418-421. 10.1038/nature01154.
Article
CAS
PubMed
Google Scholar
Kim Y, Bobbili N, Paek K, Jin H: Production of a monoclonal anti-myostatin antibody and the effects of in ovo administration of the antibody on posthatch broiler growth and muscle mass. Poult Sci. 2006, 85: 1062-1071. 10.1093/ps/85.6.1062.
Article
CAS
PubMed
Google Scholar
Bogdanovich S, Perkins KJ, Krag TO, Whittemore L-A, Khurana TS: Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J. 2005, 19: 543-549. 10.1096/fj.04-2796com.
Article
CAS
PubMed
Google Scholar
Xie H, Tao Y, Lv J, Liu P, Liu C: Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats. Evid Based Complement Alternat Med. 2013, 2013: 972863-
PubMed Central
PubMed
Google Scholar
Liu C, Hu Y, Xu L, Liu C, Liu P: Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med. 2009, 4: 12-10.1186/1749-8546-4-12.
Article
PubMed Central
PubMed
Google Scholar
Guo J, Wu W, Sheng M, Yang S, Tan J: Amygdalin inhibits renal fibrosis in chronic kidney disease. Mol Med Reports. 2013, 7: 1453-1457.
CAS
Google Scholar
Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT: Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem. 2001, 276: 17718-17726. 10.1074/jbc.M100736200.
Article
CAS
PubMed
Google Scholar